BCL2A1 and B-cell chronic lymphocytic leukemia: bfl-1 mRNA levels were determined by competitive PCR in 37 B-CLL patients, whose clinical characteristics are shown in Table 1, and correlated to in vivo response to the last chemotherapy prior to date of sampling (Figure 1A).